He succeeds Dr. Uwe Brunk, who is leaving the company at his own request, according to a press release. The change is effective Feb. 1. Schneider is currently managing director of Lanxess Elastômeros do Brasil.
He succeeds Dr. Uwe Brunk, who is leaving the company at his own request, according to a press release. The change is effective Feb. 1. Schneider is currently managing director of Lanxess Elastômeros do Brasil.

Valerie Diele-Braun resigned from her position as CEO and member of the Executive Board of IMCD at the end of April for personal reasons.

Oxea is returning to its old name and its roots.

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Novo Nordisk recently announced changes to its executive leadership and Board of Directors.

Honeywell will acquire Johnson Matthey's Catalyst Technologies business segment for €2.15 billion in an all-cash transaction.